Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Remarkable Ventures (RV) is a venture capital firm focused on early-stage investments in companies leading transformation across large industries, with a special focus on climate technology through its branch, Remarkable Ventures Climate (RVC). The firm has been investing since at least 2011 and supports over 600 founders with the help of a large, global network of mentors and operators. RV has a portfolio of nearly 100 early-stage companies and participates in programs like the Entrepreneurs Roundtable Accelerator (ERA), with four unicorns and combined portfolio value exceeding $10 billion. Remarkable Ventures is not a biotech, pharma, or healthcare company; it invests in and supports startups rather than developing clinical-stage assets or drug candidates directly. The company does not have drug programs, clinical trials, therapeutic targets, modalities, or a pipeline in the traditional biotech/pharma sense. Its portfolio includes a wide range of technology and industrial startups, not therapeutics. Its investments span sectors such as Energy Transition, Climate Fintech, Built Environment, Mobility, Manufacturing, and AgTech as part of its climate fund.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Remarkable Ventures.